Patents by Inventor T. Jesse Kwoh

T. Jesse Kwoh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treatment of hepatitis C virus-associated diseases
    Patent number: 6995146
    Abstract: Antisense oligonucleotides are provided which are complementary to and hybridizable with at least a portion of HCV RNA and which are capable of inhibiting the function of the HCV RNA. These oligonucleotides can be administered to inhibit the activity of Hepatitis C virus in vivo or in vitro. These compounds can be used either prophylactically or therapeutically to reduce the severity of diseases associated with Hepatitis C virus, and for diagnosis and detection of HCV and HCV-associated diseases. Methods of using these compounds are also disclosed.
    Type: Grant
    Filed: May 11, 2001
    Date of Patent: February 7, 2006
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Kevin P. Anderson, Ronnie C. Hanecak, Chikateru Nozaki, F. Andrew Dorr, T. Jesse Kwoh
  • Compositions and mehtods for treatment of Hepatitis C virus-associated diseases
    Publication number: 20040049021
    Abstract: Antisense oligonucleotides are provided which are complementary to and hybridizable with at least a portion of HCV RNA and which are capable of inhibiting the function of the HCV RNA. These oligonucleotides can be administered to inhibit the activity of Hepatitis C virus in vivo or in vitro. These compounds can be used either prophylactically or therapeutically to reduce the severity of diseases associated with Hepatitis C virus, and for diagnosis and detection of HCV and HCV-associated diseases. Methods of using these compounds are also disclosed.
    Type: Application
    Filed: June 4, 2003
    Publication date: March 11, 2004
    Inventors: Kevin P. Anderson, Ronnie C. Hanecak, Chikateru Nozaki, F. Andrew Dorr, T. Jesse Kwoh
  • Compositions and methods for treatment of Hepatitis C virus-associated diseases
    Publication number: 20040033978
    Abstract: Antisense oligonucleotides are provided which are complementary to and hybridizable with at least a portion of HCV RNA and which are capable of inhibiting the function of the HCV RNA. These oligonucleotides can be administered to inhibit the activity of Hepatitis C virus in vivo or in vitro. These compounds can be used either prophylactically or therapeutically to reduce the severity of diseases associated with Hepatitis C virus, and for diagnosis and detection of HCV and HCV-associated diseases. Methods of using these compounds are also disclosed.
    Type: Application
    Filed: June 9, 2003
    Publication date: February 19, 2004
    Inventors: Kevin P. Anderson, Ronnie C. Hanecak, Chikateru Nozaki, F. Andrew Dorr, T. Jesse Kwoh
  • Compositions and methods for treatment of hepatitis C virus-associated diseases
    Publication number: 20030171313
    Abstract: Antisense oligonucleotides are provided which are complementary to and hybridizable with at least a portion of HCV RNA and which are capable of inhibiting the function of the HCV RNA. These oligonucleotides can be administered to inhibit the activity of Hepatitis C virus in vivo or in vitro. These compounds can be used either prophylactically or therapeutically to reduce the severity of diseases associated with Hepatitis C virus, and for diagnosis and detection of HCV and HCV-associated diseases. Methods of using these compounds are also disclosed.
    Type: Application
    Filed: May 11, 2001
    Publication date: September 11, 2003
    Inventors: Kevin P. Anderson, Ronnie C. Hanecak, Chikateru Nozaki, F. Andrew Dorr, T. Jesse Kwoh